These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6703564)

  • 1. An endogenous digoxin-like substance and renal failure.
    Heazlewood VJ; Heazlewood RL; Jellett LB
    Ann Intern Med; 1984 Apr; 100(4):618. PubMed ID: 6703564
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed digoxin toxicity following discontinuance in acute renal failure.
    Ho AM; Fraser IM; Suria DD
    Can J Anaesth; 1987 Mar; 34(2):178-81. PubMed ID: 3829306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. False-positive digoxin measurements due to conjugated metabolite accumulation in combined renal and hepatic dysfunction.
    Vlasses PH; Besarab A; Lottes SR; Conner DP; Green PJ; Gault MH
    Am J Nephrol; 1987; 7(5):355-9. PubMed ID: 3324762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The limitations of routine total digoxin immunoassay in patients with advanced chronic kidney disease.
    Sharma R; Guy M; Rudenski A; Lamerton E; Kalra PA
    QJM; 2009 Oct; 102(10):747-50. PubMed ID: 19602599
    [No Abstract]   [Full Text] [Related]  

  • 6. XAD-4 resin hemoperfusion for digitoxic patients with renal failure.
    Hoy WE; Gibson TP; Rivero AJ; Jain VK; Talley TT; Bayer RM; Montondo DF; Freeman RB
    Kidney Int; 1983 Jan; 23(1):79-82. PubMed ID: 6834696
    [No Abstract]   [Full Text] [Related]  

  • 7. Endogenous digoxin-immunoreactive substance measured in several patient populations.
    Valdes R
    Prog Clin Biol Res; 1985; 192():221-8. PubMed ID: 4080710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous serum digoxin concentrations in patients with hepatic or renal dysfunction.
    Frewin DB; Marmanidis H; Lehmann DR; Morris RG
    Aust N Z J Med; 1986 Apr; 16(2):241-3. PubMed ID: 3463280
    [No Abstract]   [Full Text] [Related]  

  • 9. [False positive digoxin levels in the blood of patients with kidney failure before and after hemodialysis].
    Ivanović D; Duraković Z; Gjurasin M; Gasparović V; Plavsić F
    Lijec Vjesn; 1986 Jun; 108(6):245-7. PubMed ID: 3724350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH; Wu ZG; Xu JQ; Zhou Y
    Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endogenous digoxin-like substance level in essential arterial hypertension, renal failure and acromegaly].
    Soszyński P; Słowińska-Srzednicka J; Wierzbicki M
    Pol Arch Med Wewn; 1988 Jan; 79(1):20-5. PubMed ID: 3275165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretation of serum digoxin values in renal failure.
    Gault H; Vasdev S; Vlasses P; Longerich L; Dawe M
    Clin Pharmacol Ther; 1986 May; 39(5):530-6. PubMed ID: 3698461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalous serum digoxin concentrations in uremia.
    Craver JL; Valdes R
    Ann Intern Med; 1983 Apr; 98(4):483-4. PubMed ID: 6838072
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioimmunoassay of digoxin in renal failure: a comparison of different commercial kits.
    Belpaire CM; Bogaert MG; De Broe ME
    Clin Chim Acta; 1975 Jul; 62(2):255-61. PubMed ID: 1149289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loading dose of digoxin in renal failure.
    Gault MH; Churchill DN; Kalra J
    Br J Clin Pharmacol; 1980 Jun; 9(6):593-7. PubMed ID: 7387815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin like substances in chronic renal failure.
    Kumar S; Saxena SK; Gahlaut DS; Alam SM; Srivastava DK; Seth ON; Kapoor A; Rao SK
    J Assoc Physicians India; 1986 Sep; 34(9):633-4. PubMed ID: 3793697
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of digoxin analysis by high-performance liquid chromatography/post-column derivatization and fluorescence polarization immunoassay.
    Embree L; McErlane KM
    Xenobiotica; 1990 Jun; 20(6):635-43. PubMed ID: 2219957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous digoxin-like substance(s) and combined hepatic and renal failure.
    Gault MH; Vasdev SC; Longerich LL
    Ann Intern Med; 1984 Oct; 101(4):567-8. PubMed ID: 6548099
    [No Abstract]   [Full Text] [Related]  

  • 19. Digoxin-like immunoreactivity in patients with chronic renal failure.
    Slotki IN; Moreb J; Algur N; Eylath U
    Clin Nephrol; 1987 Sep; 28(3):157. PubMed ID: 3665210
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. I. Off dialysis.
    van der Vijgh WJ
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):249-54. PubMed ID: 881276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.